First-in-human report for UltiSynq CSP ICD lead ...

A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...

A first-in-human multicenter trial found the UltiSynq CSP ICD lead, designed for left bundle branch area pacing, met and exceeded safety and effectiveness goals in over 200 patients needing ICD or CRT ...

A 29-year-old man experiencing an irregular heartbeat had an unexpected solution in an area further below his heart.

Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...

Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...

Pulse Biosciences, Inc. , developer of novel nPulsetm technology using proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced late-breaking positive ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Chennai's MGM Healthcare performs innovative valve and leadless pacemaker implantation without open-heart surgery, enhancing ...

Your heart’s rhythm is more than just a beat—it’s a signal of your overall health. Understanding how it works, spotting irregularities, and making simple lifestyle changes can protect your heart for ...

In another new UAB study, 15 minutes of stimulation before a 45-minute session with a physical therapist made lasting ...

Management stated that these milestones further validate the potential benefits of nsPFA and increase awareness of the ...